Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial

BACKGROUND: Cutaneous microcystic lymphatic malformations (CMLMs) are rare conditions in children and adults. They present as clusters of vesicles full of lymph and blood to various extents, inducing maceration, esthetic impairment, pain, and impaired quality of life. The treatment is challenging. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Leducq, Sophie, Caille, Agnès, Barbarot, Sébastien, Bénéton, Nathalie, Bessis, Didier, Boccara, Olivia, Bursztejn, Anne-Claire, Chiaverini, Christine, Dompmartin, Anne, Droitcourt, Catherine, Gissot, Valérie, Goga, Dominique, Guibaud, Laurent, Herbreteau, Denis, Le Touze, Anne, Léauté-Labrèze, Christine, Lorette, Gérard, Mallet, Stéphanie, Martin, Ludovic, Mazereeuw-Hautier, Juliette, Phan, Alice, Plantin, Patrice, Quéré, Isabelle, Vabres, Pierre, Bourgoin, Hélène, Giraudeau, Bruno, Maruani, Annabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918625/
https://www.ncbi.nlm.nih.gov/pubmed/31847908
http://dx.doi.org/10.1186/s13063-019-3767-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918625/
https://www.ncbi.nlm.nih.gov/pubmed/31847908
http://dx.doi.org/10.1186/s13063-019-3767-8

Ejemplares similares